TERT and urinary bladder cancer: Detailed information of the tissue histologies as well as the mutational status for the TERT promoter for the polyclonal events are displayed in Figure 2A. Monoclonal whole-organ mapping bladder cancer specimens are illustrated in Figure 2B, where a −124 mutation was found in MIBC, CIS and tumor associated normal urothelium.